First Safety Study in Humans of a Single Dose of CPG 52364
Status:
Completed
Trial end date:
2008-04-01
Target enrollment:
Participant gender:
Summary
Determine the safety and tolerability of the study drug, CPG 52364, when given as liquid or
capsule. Another purpose is to determine how the drug enters and leaves the blood stream and
body tissues over time.